Method for identifying macrophages in oral periodontal tissue and application of method
Through single-cell sequencing technology and gene expression analysis, the problem of macrophage identification in oral periodontal tissue is solved, the accurate identification and subpopulation division of macrophages is achieved, and the diagnosis and treatment of diseases such as periodontitis is provided. New basis.
Patent Information
- Application Number
- CN202410930496.6
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-11
- Publication Date
- 2024-11-08
AI Technical Summary
It is difficult for the prior art to effectively identify and isolate macrophages in oral periodontal tissue, especially due to their small proportion in periodontal tissue and environmental complexity, it is difficult for traditional methods to achieve accurate identification.
Using single-cell sequencing technology, through high-throughput sequencing and quantitative analysis of gene expression, combined with dimensionality reduction grouping and differential gene expression analysis, macrophages in oral periodontal tissue are identified and annotated, and subdivided into multiple subpopulations, using characteristics Genes and metabolic pathways are functionally annotated.
The accurate identification and subpopulation division of macrophages in oral periodontal tissues has been achieved, providing a targeted basis for the diagnosis and treatment of diseases such as periodontitis, and improving the understanding and research ability of the oral immune environment.
Smart Images

Figure CN118910269A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the field of bioinformatics, and in particular to a method for identifying macrophages in oral periodontal tissues and an application thereof. Background Art
[0002] Macrophages are an important part of the immune system and are responsible for immune surveillance and response. They can identify pathogens, damaged cells and tumor cells in the body and remove these harmful substances by secreting cytokines, thereby regulating the immune response and maintaining homeostasis in the body. Therefore, macrophages play a vital role in resisting infection, repairing tissue damage, and participating in chronic inflammatory and autoimmune diseases.
[0003] In the oral environment, macrophages also play a vital role, especially in the occurrence and development of various oral diseases such as periodontal disease, dental caries and oral cancer. Among them, since periodontal tissues such as gingiva, periodontal ligament, alveolar bone and cementum are often affected by bacterial infection, mechanical stress and microbial invasion, the environment is relatively complex, so macrophages located in these parts often play a more important role in controlling inflammatory responses, clearing pathogens and maintaining tissue homeostasis.
[0004] By identifying macrophages in oral periodontal tissues, we can gain a deeper understanding of the immune environment in the oral cavity and provide important support for basic oral science research. In addition, chronic oral inflammation such as periodontitis may trigger a systemic inflammatory response, and systemic diseases (such as diabetes, cardiovascular disease, and rheumatic diseases) may also affect the oral environment through inflammatory and immune mechanisms. Therefore, identifying macrophages in oral periodontal tissues is also important for revealing the mechanisms of related diseases and discovering new therapeutic targets.
[0005] Although the importance of identifying macrophages in oral periodontal tissues is becoming increasingly apparent, these cells account for only about 5% of the periodontal tissues, making it difficult to effectively separate and identify them using traditional biomolecular methods such as flow cytometry. In addition, the complex environment of periodontal tissues and the heterogeneity of macrophages further increase the difficulty of identification. Therefore, it is urgent to develop new technologies and methods to achieve the identification and study of macrophages in oral periodontal tissues. Summary of the invention
[0006] The present invention is based on single-cell sequencing technology and provides a method for identifying macrophages in oral periodontal tissues and its application by analyzing the differential gene expression of different types of cells.
[0007] In a first aspect, the present invention provides a method for identifying macrophages in oral periodontal tissues, comprising: S1, collecting single cell samples from oral periodontal tissues; S2, performing high-throughput sequencing on the single cell samples to obtain original sequence data; S3, performing gene expression quantitative analysis on the original sequence data to obtain an expression matrix; and S4, performing dimensionality reduction and clustering on the expression matrix, and annotating the cell types of immune cells in the oral periodontal tissues through differential gene expression analysis to identify macrophages.
[0008] In some embodiments, step S4 includes: S41, performing dimensionality reduction and clustering on the expression matrix to divide the immune cells in the oral periodontal tissue into different immune cell subtypes; S42, using the non-parametric Wilcoxon rank sum test to calculate the average expression and dispersion of different genes in the immune cell subtypes; S43, using Seurat to identify differentially expressed genes between different immune cell subtypes; and S44, manually annotating the macrophages based on the differentially expressed genes between the immune cell subtypes, wherein the characteristic genes of the macrophages include any one or more of Sepp1, Rnase1, C1qa, Apoe, C1qb, Cd14, and Lyve1.
[0009] In some embodiments, the step S4 further includes: S45, automatically annotating immune cell subtypes based on a self-built database using the SignleR software package.
[0010] In some embodiments, in step S41, the expression data of the top 4000 genes with the highest variability are selected for dimensionality reduction, principal components are extracted, and cluster analysis is performed based on the top 50 principal components.
[0011] In some embodiments, the method for identifying macrophages in oral periodontal tissues further comprises: S5, annotating the macrophages in oral periodontal tissues by cell type through dimensionality reduction clustering and differential gene expression analysis, and identifying macrophage subpopulations.
[0012] In some embodiments, the step S5 includes: S51, using the principal component analysis method to reduce the dimension of the expression matrix and divide the macrophages in the oral periodontal tissue into different macrophage subpopulations; and S52, using the FindAllMarkers function to determine the differentially expressed genes of the macrophage subpopulations, and manually annotating the macrophage subpopulations based on the differentially expressed genes.
[0013] In some embodiments, the step S5 further comprises: S53, manually annotating the functional characteristics of the macrophage subpopulation using a GO / KEGG pathway enrichment analysis method.
[0014] In some embodiments, step S3 includes performing quality control on the expression matrix, including removing cells expressing less than 200 genes or more than 5000 genes, and cells expressing more than 15% of mitochondrial genes and more than 3% of hemoglobin genes.
[0015] In some embodiments, the macrophage subpopulation in step S5 includes Ma.1, which is associated with T cell activation and has characteristic genes C1qa, Ms4a7 and Mpeg1; Ma.2, which is associated with monocyte differentiation and has characteristic genes II1rn, I fitm1 and Thbs1; Ma.3, which is associated with lipopolysaccharide response and has characteristic genes Atf3, Cc l4 and Rgs1; Ma.4, which is associated with wound healing pathway and has characteristic genes Mmp12, Hspa1a and Hspa1b; and Ma.5, which is associated with leukocyte inflammatory response and has characteristic genes Trac, Cd3d and Trbc2.
[0016] In a second aspect, the present invention provides the use of the above method for identifying macrophages in oral periodontal tissue in developing products for diagnosing, preventing or treating oral periodontitis.
[0017] Compared with the prior art, the present invention has the following beneficial effects:
[0018] The present invention is based on single-cell mRNA sequencing technology, combined with bioinformatics analysis methods such as quantitative analysis of gene expression, quality control and standardization, to divide the immune cells in oral periodontal tissues. By comparing differential gene expression and metabolic pathway responses, accurate identification of macrophages in oral periodontal tissues is achieved. In addition, the present invention further annotates the cell types of macrophages and subdivides them into five macrophage subsets. In view of the close relationship between macrophages in oral periodontal tissues and systemic diseases, these macrophage subsets can be used as a basis for targeted treatment of oral-related diseases such as periodontitis. BRIEF DESCRIPTION OF THE DRAWINGS
[0019] Figure 1 is a flow chart for identifying macrophages in oral periodontal tissues in one embodiment;
[0020] Figure 2 A t-SNE diagram of immune cell subpopulation types in one embodiment;
[0021] Figure 3 A flowchart of identifying macrophage subpopulations in oral periodontal tissues in one embodiment;
[0022] Figure 4 is a t-SNE diagram of macrophage subpopulation types in one embodiment;
[0023] Figure 5 is a differential gene expression diagram of macrophage subpopulations in one embodiment;
[0024] FIG. 6 is a diagram showing the expression of macrophage subpopulation molecular markers in an embodiment, wherein Figure 6-1 to Figure 6-5 They are Ma.1 macrophage subset, Ma.2 macrophage subset, Ma.3 macrophage subset, Ma.4 macrophage subset, and Ma.5 macrophage subset. DETAILED DESCRIPTION
[0025] The technical solution of this patent will be further described in detail below in conjunction with specific implementation methods. It should be noted that the following detailed descriptions are exemplary and are intended to provide further explanation of this application. Unless otherwise specified, all technical and scientific terms used herein have the same meanings as those commonly understood by ordinary technicians in the technical field to which this application belongs.
[0026] Example 1
[0027] like Figure 1 As shown, this embodiment provides a method for identifying macrophages in oral periodontal tissues, including: S1, collecting single cell samples from oral periodontal tissues; S2, performing high-throughput sequencing on the single cell samples to obtain original sequence data; S3, performing gene expression quantitative analysis on the original sequence data to obtain an expression matrix; and S4, performing dimensionality reduction and clustering on the expression matrix, and annotating the cell types of immune cells in oral periodontal tissues through differential gene expression analysis to identify macrophages, as shown in the following.
[0028] S1. Collect single cell samples from oral periodontal tissue.
[0029] First, pass the 5-0 silk thread through the interdental space between the second and third molars, and between the first and second molars, then wrap the suture around the second molar and tie it securely with a triple knot. Subsequently, use spring scissors to cut the excess suture, ensuring that only the necessary part is retained. Next, gently tie the 5-0 silk thread on both sides of the maxillary second molars of mice treated with periodontitis and keep it for 7 days to simulate the periodontitis environment, thereby constructing a periodontitis mouse model.
[0030] Tissue samples with a diameter of 2 mm were obtained from the lesions of the periodontitis mouse model. The obtained periodontal tissues were cut and washed three times with PBS. Then, the tissues were digested in a solution of 1 mg / mL collagenase A and 0.5 mg / mL DNase I at 37°C for 20 minutes, followed by the addition of 0.5 M EDTA and continued digestion at the same temperature for 20 minutes. Afterwards, CD45 + For immune cells, the suspension was passed through a cell strainer and centrifuged to prepare a single-cell sample.
[0031] S2. Perform high-throughput sequencing on single-cell samples to obtain raw sequence data.
[0032] Single-cell samples are loaded into a microfluidic device for cell lysis, releasing intracellular mRNA. Next, the mRNA is converted into cDNA by reverse transcription, and a specific cell barcode and unique molecular identifier are added. The cDNA obtained by reverse transcription is then amplified by PCR, and the amplified cDNA is further fragmented and sequencing adapters are added to construct a single-cell RNA sequencing (scRNA-seq) library. In this process, a single-cell RNA sequencing (scRNA-seq) library is constructed using a single-cell RNA sequencing (scRNA-seq) library. Single-cell RNA library kit.
[0033] The constructed library was diluted to 4 nM concentration to meet the requirements of the subsequent high-throughput sequencing platform. Subsequently, the diluted libraries were merged in a certain ratio so that multiple samples could be sequenced simultaneously in one sequencing run. Then, sequencing was performed on the Illumina NovaSeq 6000 platform using a 150 bp paired-end reading mode. Finally, a FASTQ file, i.e., raw sequence data, was generated.
[0034] S3. Perform quantitative gene expression analysis on the original sequence data to obtain an expression matrix.
[0035] CellScope was used to trim the raw sequence data and remove low-quality reads and adapter sequences. The cleaned FASTQ files were then sequence aligned, the reads were mapped to the reference genome mouse genome GRCm38 (version 92), and an alignment file was generated. By extracting cell barcodes and unique molecular identifiers, the alignment files were deduplicated and quantitatively analyzed for gene expression, and finally a gene count file was generated. Finally, all gene count files were aggregated to generate a gene expression matrix for each sample.
[0036] The Seurat software package was used to perform quality control and standardization on the expression matrix, including removing cells expressing less than 200 genes or more than 5000 genes, as well as cells with mitochondrial gene expression ratios exceeding 15% and hemoglobin gene expression ratios exceeding 3%, and performing batch correction between samples to obtain a standardized expression matrix for downstream analysis.
[0037] S4. The expression matrix was clustered by dimensionality reduction, and the cell types of immune cells in oral periodontal tissues were annotated through differential gene expression analysis, and macrophages were identified.
[0038] The expression patterns of all intracellular genes were analyzed, and the top 4,000 genes with the highest variability were selected from the expression matrix. Then, principal component analysis was used to reduce the dimensionality of the expression data of these highly variable genes and extract the most important eigenvalues, i.e., principal components. Then, based on the first 50 principal components, cluster analysis was performed using different parameters to divide the immune cells in the oral periodontal tissue into different subtypes, and a t-SNE graph of the immune cell subpopulation types was output.
[0039] The nonparametric Wilcoxon rank sum test was used to calculate the mean expression and dispersion of each gene in the oral periodontal tissue immune cell subtypes. Subsequently, the Seurat software package was used for statistical analysis to evaluate the similarity ratio of the mean expression and the percentage of expressing cells to identify differentially expressed genes (DEGs) between different immune cell subtypes, with the significance level set at P < 0.05. Based on the expression differences of different transcription factors, macrophages in oral periodontal tissue immune cells were annotated in detail, with special attention paid to characteristic genes such as Sepp1, Rnase1, C1qa, Apoe, C1qb, Cd14, and Lyve1.
[0040] On the basis of differential gene expression analysis, GO / KEGG pathway enrichment analysis was performed to further study the biological functions of macrophages in oral periodontal tissue immune cells, and macrophages were annotated with functional characteristics.
[0041] In addition, the cell type annotation process can also refer to the database annotation of the SingleR software package, that is, SingleR automatically annotates single-cell transcriptome subpopulations based on a self-built database. This embodiment adopts a parallel strategy, combining manual annotation and the annotation scheme of the SingleR software package to ensure a comprehensive understanding and accurate annotation of immune cell subpopulations. In practical applications, a suitable annotation method can be selected according to specific needs to achieve the purpose of immune cell annotation.
[0042] Based on the above-mentioned identification method of macrophages in oral periodontal tissues, the following results were obtained.
[0043] Figure 2The t-SNE graph of immune cell subsets is shown, and different grayscales represent different immune cell subsets. It can be seen that the main immune cell types in oral periodontal tissues include B cells, T cells, and neutrophils, while the number of macrophages is relatively small. In addition, the distance between macrophages and dendritic cells (DC), monocytes, and gamma delta T cells (Tgd) is close, indicating that these immune cell subsets have similarities in gene expression profiles.
[0044] Example 2
[0045] like Figure 3 As shown, based on Example 1, this example sets step S5 to annotate the cell types of macrophages in oral periodontal tissues and identify macrophage subpopulations through dimensionality reduction clustering and differential gene expression analysis, as follows.
[0046] By selecting highly variable genes, using principal component analysis for dimensionality reduction, and then performing cell clustering analysis based on principal components, macrophages in oral periodontal tissues were divided into different subtypes, and t-SNE graphs were generated to visualize macrophage subpopulations. Afterwards, the FindAllMarkers function was used to identify differentially expressed genes in each macrophage subpopulation, and macrophage subpopulations were manually annotated based on these marker genes.
[0047] On the basis of differential gene expression analysis, the gsfisher R package was used to perform enrichment analysis on the significantly upregulated gene sets, and the corresponding gene sets were annotated from the Gene Ontology (GO) database. This embodiment mainly uses the biological process (BP) entry in the GO database to explore the metabolic pathways of each macrophage subset. In practical applications, the Cellular Component (CC) and Molecular Function (MF) entries in the GO database can also be used for a more comprehensive study.
[0048] Based on the above-mentioned identification method of macrophage subsets in oral periodontal tissues, the following results were obtained.
[0049] Figure 4 The t-SNE graph of macrophage subpopulations is shown. According to the transcription factor type, transcriptional activity and functional characteristics, macrophages are divided into five subpopulations - Ma.1, Ma.2, Ma.3, Ma.4 and Ma.5. Different grayscales represent different macrophage subpopulations. Figure 5 Figure 6 shows the differential gene expression of each macrophage subset. Figure 6 further shows the expression of characteristic molecular markers of each macrophage subset through a series of violin plots. Figure 6-1 to Figure 6-5 Corresponding to Ma.1, Ma.2, Ma.3, Ma.4 and Ma.5 in order.
[0050] It can be seen that the macrophage subset Ma.1 highly expresses C1qa, Ms4a7 and Mpeg1, indicating that it has strong phagocytic ability and is associated with T cell activation. The characteristic genes of Ma.2 include Ⅱ1rn, I fitm1 and Thbs1. The upregulation of these genes indicates that it may be an anti-inflammatory M2 macrophage and is enriched in the monocyte differentiation process. Ma.3 highly expresses Atf3, Cc l4 and Rgs1, indicating that it is active in lipopolysaccharide response, similar to the M1 macrophage phenotype. Ma.4 highly expresses Mmp12, Hspa1a and Hspa1 b, indicating that it is associated with the wound healing pathway. The characteristic genes of Ma.5 include Trac, Cd3d and Trbc2, and the upregulated genes indicate that it is similar to Tcr + Macrophages have strong phagocytic ability and anti-inflammatory effects, and are enriched in the inflammatory response process of leukocytes.
[0051] The method for identifying macrophages in oral periodontal tissues provided by the present invention provides a new tool for oral immune research, which can be used for basic research and technology development to reveal immune regulation mechanisms and potential therapeutic targets. Considering the diversity and functional complexity of macrophages, as well as the non-specificity of macrophages associated with diseases, the above-mentioned identification method can also be used to confirm the individual's physical condition by evaluating the status of other immune cells, analyzing the oral tissue microenvironment, and combining multidisciplinary knowledge such as immunology, pathology, and molecular biology.
[0052] The above are only some embodiments of the present invention. For those skilled in the art, several modifications and improvements can be made without departing from the creative concept of the present invention, which all belong to the protection scope of the present invention.
Claims
1. A method for identifying macrophages in oral periodontal tissues, It is characterized in that include: S1. Collect single cell samples from oral periodontal tissues; S2. performing high-throughput sequencing on the single cell sample to obtain original sequence data; S3, performing quantitative gene expression analysis on the original sequence data to obtain an expression matrix; and S4. The expression matrix is subjected to dimensionality reduction and clustering, and the cell types of immune cells in oral periodontal tissues are annotated through differential gene expression analysis to identify macrophages.
2. The method for identifying macrophages in oral periodontal tissue according to claim 1, It is characterized in that The step S4 comprises: S41, performing dimensionality reduction and clustering on the expression matrix to divide the immune cells in the oral periodontal tissue into different immune cell subtypes; S42, using the non-parametric Wilcoxon rank sum test to calculate the average expression and dispersion of different genes in the immune cell subtypes; S43, using Seurat to identify differentially expressed genes between different immune cell subtypes; and S44. Manually annotate the macrophages according to the differentially expressed genes between the immune cell subtypes, wherein the characteristic genes of the macrophages include any one or more of Sepp1, Rnase1, C1qa, Apoe, C1qb, Cd14, and Lyve1.
3. The method for identifying macrophages in oral periodontal tissue according to claim 4, It is characterized in that The step S4 further comprises: S45. Build a database based on the SingleR software package to automatically annotate immune cell subtypes.
4. The method for identifying macrophages in oral periodontal tissue according to claim 4, It is characterized in that In the step S41, The expression data of the top 4000 genes with the highest variability were selected for dimensionality reduction, principal components were extracted, and cluster analysis was performed based on the top 50 principal components.
5. The method for identifying macrophages in oral periodontal tissue according to any one of claims 1 to 4, It is characterized in that Also includes: S5. Through dimensionality reduction clustering and differential gene expression analysis, the cell types of the macrophages in the oral periodontal tissues were annotated and macrophage subpopulations were identified.
6. The method for identifying macrophages in oral periodontal tissue according to claim 5, It is characterized in that The step S5 comprises: S51, using a principal component analysis method to perform dimensionality reduction and clustering on the expression matrix, and dividing the macrophages in the oral periodontal tissue into different macrophage subpopulations; and S52. Using the FindAllMarkers function, determine the differentially expressed genes of the macrophage subpopulation, and manually annotate the macrophage subpopulation based on the differentially expressed genes.
7. The method for identifying macrophages in oral periodontal tissue according to claim 6, It is characterized in that The step S5 further comprises: S53. Use the GO / KEGG pathway enrichment analysis method to manually annotate the functional characteristics of the macrophage subpopulation.
8. The method for identifying macrophages in oral periodontal tissue according to any one of claims 1 to 4, It is characterized in that The step S3 comprises: The expression matrix was subjected to quality control, including removal of cells expressing less than 200 genes or more than 5000 genes, as well as cells expressing more than 15% of mitochondrial genes and more than 3% of hemoglobin genes.
9. The method for identifying macrophages in oral periodontal tissue according to claim 7, It is characterized in that The macrophage subpopulation in step S5 includes: The characteristic genes are C1 qa, Ms4a7, and Mpeg1, and Ma.1, which is associated with T cell activation; The characteristic genes were Ⅱ1rn, Ifitm1, and Thbs1, and Ma.2, which was associated with monocyte differentiation; The characteristic genes are Atf3, Ccl4 and Rgs1, and Ma.3 related to lipopolysaccharide response The characteristic genes are Mmp12, Hspa1 a and Hspa1 b, and Ma.4 related to the wound healing pathway; and The characteristic genes were Trac, Cd3d and Trbc2, and Ma.5 which was related to leukocyte inflammatory response.
10. Use of the method for identifying macrophages in oral periodontal tissue according to any one of claims 1 to 9 in developing products for diagnosing, preventing or treating oral periodontitis.
